Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Akalin, Altuna Dr. (1) Cöl Arslan, Seda Dr. (1) Daumke, Oliver Prof. Dr. (2) Franke, Vedran Dr. (1) Gavvovidis, Ioannis Dr. (1) Heinemann, Udo Prof. Dr. (1) Hinz, Michael Dr. (2) Hinze, Christian Dr. med. Dipl.-Math. (1) Höpken, Uta Elisabeth PD Dr. (1) Hübner, Norbert Prof. Dr. (1) Kärgel, Eva Dr. (1) Kempa, Stefan Dr. (1) Kettenmann, Helmut Prof. Dr. (1) Kieback, Elisa Dr. (1) Kolesnichenko, Marina Dr. (1) Landthaler, Markus Prof. Dr. (1) Leisegang, Matthias Dr. (4) Lorenz, Felix Dr. (3) Marko, Lajos Dr. (1) Mastrobuoni, Guido Dr. (1) Müller, Dominik Prof. Dr. (1) Müller, Gerd Dr. (1) Obenaus, Matthias (1) Patone, Giannino Dr. (1) Poncette, Lucia (1) Scheidereit, Claus Prof. Dr. (4) Schmidt-Ott, Kai Prof. Dr. (1) Schmidt-Ullrich, Ruth Dr. (6) Schmitt, Clemens Prof. Dr. (1) Schütz, Anja Dr. (1) Selbach, Matthias Prof. Dr. (1) Uckert, Wolfgang Prof. Dr. (10) Wolf, Jana Prof. Dr. (1) Wyler, Emanuel Dr. (1) Yilmaz, Zekiye Buket Dr. (1) (-) Blankenstein, Thomas Prof. Dr. (5) (-) Mathas, Stephan Dr. (1) 1998 (2) 2000 (2) 2002 (2) 2003 (5) 2004 (1) 2005 (4) 2006 (2) 2007 (1) 2008 (1) 2010 (1) (-) 2011 (2) 2013 (1) 2014 (2) (-) 2015 (2) 2016 (2) 2017 (1) 2018 (1) (-) 2019 (2) Bioinformatics (1) Biology of Malignant Lymphomas (11) Genetics and Genomics of Cardiovascular Diseases (1) (-) Molecular Cell Biology and Gene Therapy (5) Molecular Immunology and Gene Therapy (14) Molecular Immunotherapy (3) Proteome Dynamics (1) (-) Signal Transduction in Tumor Cells (1) Structural Biology of Membrane-Associated Processes (1) Systems Biology of Gene Regulatory Elements (1) 6 Results: Active Filter: Blankenstein, Thomas Prof. Dr.Mathas, Stephan Dr.Molecular Cell Biology and Gene TherapySignal Transduction in Tumor Cells201120152019 Sort: Result score Newest to oldest Oldest to newest March 28, 2019 in Blood Autocrine LTA signaling drives NF-κB and JAK-STAT activity and myeloid gene expression in Hodgkin lymphoma L. von Hoff E. Kärgel V. Franke E. McShane K.W. Schulz-Beiss G. Patone N. Schleussner M. Kolesnichenko N. Hübner O. Daumke M. Selbach A. Akalin S. Mathas C. Scheidereit January 02, 2019 in J Clin Invest Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression L. Poncette X. Chen F.K.M. Lorenz T. Blankenstein April 01, 2015 in Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber April 01, 2015 in Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein July 28, 2011 in Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein January 15, 2011 in Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens
March 28, 2019 in Blood Autocrine LTA signaling drives NF-κB and JAK-STAT activity and myeloid gene expression in Hodgkin lymphoma L. von Hoff E. Kärgel V. Franke E. McShane K.W. Schulz-Beiss G. Patone N. Schleussner M. Kolesnichenko N. Hübner O. Daumke M. Selbach A. Akalin S. Mathas C. Scheidereit
January 02, 2019 in J Clin Invest Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression L. Poncette X. Chen F.K.M. Lorenz T. Blankenstein
April 01, 2015 in Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber
April 01, 2015 in Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein
July 28, 2011 in Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein
January 15, 2011 in Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens
